A crucial issue confronting the global AIDS community is the extreme inequalities in access to treatments for HIV and related infections. Initiatives taken by the governments of some developing countries to expand access through the use of parallel importing and compulsory licensure have met with opposition from the pharmaceutical industry and the U.S. government. This presentation will delineate 1) the formation of a coalition of AIDS activists, public health and medical personnel, and public safety experts in the U.S. who are committed to broadening global access to HIV-related treatments, and 2) the strategy and tactics that they have utilized to successfully impact on U.S. government trade policies.
Learning Objectives: At the end of the presentation, the participant should be able to understand the role that a broad coalition of individuals has had in organizing to protest against U.S. trade policies and to expand global access to HIV-related treatments
Keywords: Drugs, HIV/AIDS
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.
The 128th Annual Meeting of APHA